Adeona gets $1M from Seaside 88
Adeona Pharmaceuticals, based in Ann Arbor, MI., has received $1 million in equity financing from Florida-based investor Seaside 88, Adeona announced today. The financing involved the sale of 1,212,121 shares of stock. Adeona is working on a “prescription medical food” called Zinthionein ZC for treatment of Alzeimer’s disease and mild cognitive impairment. The company also announced that it has enrolled 75 percent of a 60-patient clinical study of Zinthionein ZC.